ECZEMA ATOPIC DERMATITIS
Clinical trials for ECZEMA ATOPIC DERMATITIS explained in plain language.
Never miss a new study
Get alerted when new ECZEMA ATOPIC DERMATITIS trials appear
Sign up with your email to follow new studies for ECZEMA ATOPIC DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eczema drug shows promise in early trial
Disease control CompletedThis study tested a new medicine called camoteskimab in 62 adults with moderate to severe eczema (atopic dermatitis). The goal was to see if it could reduce skin redness, itching, and rash better than a placebo over 12 weeks. Participants received either the drug or a placebo, an…
Matched conditions: ECZEMA ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New eczema drug shows promise in early trial
Symptom relief CompletedThis study tested an experimental drug, EVO301, in 71 adults with moderate-to-severe atopic dermatitis (eczema). The goal was to see if the drug safely reduces skin redness, thickness, and itch. Participants received either EVO301 or a placebo, and doctors measured changes in ski…
Matched conditions: ECZEMA ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Symptom relief
Last updated May 26, 2026 10:35 UTC
-
AI boosts skin diagnosis accuracy for rare conditions
Knowledge-focused CompletedThis study tested whether an artificial intelligence (AI) tool could help doctors more accurately diagnose rare and tricky skin conditions like generalized pustular psoriasis. Fifteen general practitioners and dermatologists reviewed 100 skin images, first giving their own diagno…
Matched conditions: ECZEMA ATOPIC DERMATITIS
Sponsor: AI Labs Group S.L • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC